TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
OBIO

Orchestra BioMed Holdings Inc.

Healthcare · Biotechnology

5.90$ -4.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement OBIO
Line item 2020 2021 2022 2023 2024 2025
– -113.7% – -21.9% -4.4% +1,169.2%
– +37.2% +61.8% -42.2% +9.7% -6.9%
– -117.7% – -19.8% -5.4% +1,267.8%
– -4.4% +70.2% +54.1% +26.6% +35.9%
– -26.8% +77.0% +44.3% +18.1% +12.5%
– -14.4% +72.3% +50.8% +23.4% +27.5%
– – – – – –
– – – – – –
– – – – – –
– -64.4% -123.9% – – –
– – – – – –
– – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?